Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kovax Influ Tetra PF Inj
- Development stage
- Unknown
- Lead developer
- Koreavaccine
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
**Kovax Influ Tetra PF Inj** is a Korea Vaccine seasonal quadrivalent split-virion, inactivated influenza vaccine for prevention of influenza caused by influenza A and influenza B viruses. It presents purified inactivated antigens from four influenza vaccine strains and induces active protective immune responses, including strain-specific antibody responses, rather than treating established influenza infection. The product is approved in South Korea and is supplied as an injection. ([en-koreavaccine.uriweb.kr](https://en-koreavaccine.uriweb.kr/109))
- Brand names
- Kovax Influ 4ga PF Injection (PFS)Kovax Influ Tetra PF Inj코박스인플루4가PF주
- Other names
- Kovax Influ Quadrivalent PF Inj
02
Targets
HA (Hemagglutinin (Influenza B virus Yamagata lineage))HA (Hemagglutinin (Influenza B virus Victoria lineage))HA (Hemagglutinin (Influenza A virus H3N2))Neuraminidase
Beyond the preview
Go deeper on Kovax Influ Tetra PF Inj.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kovax Influ Tetra PF Inj.